Agency Information Collection Activities: Submission for OMB Review; Comment Request, 45662-45663 [2024-11291]
Download as PDF
45662
Federal Register / Vol. 89, No. 101 / Thursday, May 23, 2024 / Notices
h. Medicare Enrollment time frames:
Effective and termination dates
i. Medicare and VHA Dual enrollment
timeframes: Effective and termination
dates
j. Date of death
System(s) of Records
The records used in the matching
program will be disclosed from the
following systems of records, as
authorized by routine uses published in
the system of records notices (SORNs)
cited below:
lotter on DSK11XQN23PROD with NOTICES1
A. Systems of Records Maintained by
CMS
1. Common Working File (CWF),
System No. 09–70–0526, last published
in full at 71 FR 64955 (Nov. 6, 2006),
and partially updated at 78 FR 23938
(Apr. 23, 2013), 78 FR 32257 (May 29,
2013), and 83 FR 6591 (Feb. 14, 2018).
Routine uses 2a and 10 authorize
disclosures to VHA to contribute to the
accuracy of CMS’ proper payment of
Medicare benefits, and to investigate
potential fraud, waste, or abuse.
2. Medicare Beneficiary Database
(MBD), System No. 09–70–0536, last
published in full at 71 FR 70396 (Dec.
4, 2006), and partially updated at 78 FR
23938 (Apr. 23, 2013), 78 FR 32257
(May 29, 2013), and 83 FR 6591 (Feb.
14, 2018). Routine uses 2a and 11
authorize disclosures to VHA to
contribute to the accuracy of CMS’s
proper payment of Medicare benefits,
and to investigate potential fraud, waste,
or abuse.
3. Medicare Integrated Data
Repository (IDR), System No. 09–70–
0571, last published in full at 71 FR
74915 (Dec. 13, 2006), and partially
updated 76 FR 65196 (Oct. 20, 2011), 78
FR 23938 (Apr. 23, 2013), 78 FR 32257
(May 29, 2013), and 83 FR 6591 (Feb.
14, 2019). Routine uses 2a and 11
authorize disclosures to VHA to
contribute to the accuracy of CMS’s
proper payment of Medicare benefits,
and to investigate potential fraud, waste,
or abuse.
4. National Claims History (NCH),
System No. 09–70–0558, last published
in full at 71 FR 67137 (Nov. 20, 2006),
and partially updated at 76 FR 65196
(Oct 20, 2011), 78 FR 23938 (Apr. 23,
2013), 78 FR 32257 (May 29, 2013), and
83 FR 6591 (Feb. 14, 2018). Routine uses
2a and 10 authorize disclosure to VHA
to contribute to the accuracy of CMS’s
proper payment of Medicare benefits,
and to investigate potential fraud, waste,
or abuse.
VerDate Sep<11>2014
18:47 May 22, 2024
Jkt 262001
B. Systems of Records Maintained by
VHA
minimize the information collection
burden.
1. SOR 147VA10, entitled
‘‘Enrollment and Eligibility RecordVA,’’ last published at 86 FR 46090
(Aug. 17, 2021). Routine use 12
authorizes disclosures to federal
agencies for purposes of preventing and
detecting possible fraud or abuse by
individuals in their operations and
programs.
2. SOR 23VA10NB3, entitled ‘‘NonVA Care (Fee) Records,’’ last published
at 80 FR 45590 (July 30, 2015). Routine
use 12 authorizes disclosures to CMS for
its use in identifying potential duplicate
payments for healthcare services paid
by VA and CMS. Routine use 30
authorizes disclosure to assist in
preventing and detecting possible fraud
or abuse by individuals in federal
programs.
DATES:
[FR Doc. 2024–11351 Filed 5–22–24; 8:45 am]
BILLING CODE 4120–03–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10526]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
SUMMARY:
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
Comments on the collection(s) of
information must be received by the
OMB desk officer by June 24, 2024.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Extension without change of a
currently approved collection; Title of
Information Collection: Cost-Sharing
Reduction Reconciliation Use: Under
established Department of Health and
Human Services (HHS) regulations,
although cost-sharing reduction (CSR)
payments are not being advanced to
qualified health plan (QHP) issuers at
the present time, issuers are still
permitted to submit data that compares
the CSR-eligible enrollment for each
issuer with their actual CSRs provided
SUPPLEMENTARY INFORMATION:
E:\FR\FM\23MYN1.SGM
23MYN1
Federal Register / Vol. 89, No. 101 / Thursday, May 23, 2024 / Notices
by the issuer for covered services for
each eligible enrollee in a benefit year.
HHS will compare this CSR-eligible
enrollment with the actual CSRs
provided by the issuers that participate
in the optional data submission window
to verify the issuer’s reporting of CSRs
provided. This revised collection does
not add any data elements and
continues to make summary plan level
reporting optional.
Based upon CMS’ experience in the
CSR data collection and evaluation
process, CMS is not making any
substantive changes to this information
collection. Form Number: CMS–10526
(OMB Control Number: 0938–1266);
Frequency: Annually; Affected Public:
Private Sector, Business or other forprofit and not-for-profit institutions;
Number of Respondents: 150; Number
of Responses: 150 Total Annual Hours:
2,363. (For policy questions regarding
this collection, contact Deborah Noymer
at 301–448–3755.)
William N. Parham, III,
Director, Division of Information Collections
and Regulatory Impacts, Office of Strategic
Operations and Regulatory Affairs.
[FR Doc. 2024–11291 Filed 5–22–24; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2000–D–0784]
International Cooperation on
Harmonisation of Technical
Requirements for Registration of
Veterinary Medicinal Products; Studies
to Evaluate the Safety of Residues of
Veterinary Drugs in Human Food:
Reproduction Testing (Revision 1);
Draft Guidance for Industry;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
lotter on DSK11XQN23PROD with NOTICES1
VerDate Sep<11>2014
18:47 May 22, 2024
Jkt 262001
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a draft
revised guidance for industry (GFI) #115
(VICH GL22) entitled ‘‘Studies to
Evaluate the Safety of Residues of
Veterinary Drugs in Human Food:
Reproduction Testing (Revision 1).’’
This draft guidance has been developed
for veterinary use by the International
Cooperation on Harmonisation of
Technical Requirements for Registration
of Veterinary Medicinal Products
(VICH). In order to establish the safety
of veterinary drug residues in human
food, a number of toxicological
SUMMARY:
evaluations are required, including the
assessment of any effects on
reproduction. The objective of this
guidance is to ensure international
harmonization of reproduction testing
that is appropriate for the evaluation of
effects on reproduction from long-term,
low-dose exposures; these effects may
be encountered from the presence of
veterinary drug residues in food.
DATES: Submit either electronic or
written comments on the draft guidance
by July 22, 2024 to ensure that the
Agency considers your comment on this
draft guidance before it begins work on
the final version of the guidance.
ADDRESSES: You may submit comments
on any guidance at any time as follows:
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
45663
2000–D–0784 for ‘‘Studies to Evaluate
the Safety of Residues of Veterinary
Drugs in Human Food: Reproduction
Testing (Revision 1).’’ Received
comments will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday
through Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
You may submit comments on any
guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for single
copies of the guidance to the Policy and
Regulations Staff (HFV–6), Center for
Veterinary Medicine, Food and Drug
Administration, 7500 Standish Pl.,
Rockville, MD 20855. Send one selfaddressed adhesive label to assist that
office in processing your requests. See
E:\FR\FM\23MYN1.SGM
23MYN1
Agencies
[Federal Register Volume 89, Number 101 (Thursday, May 23, 2024)]
[Notices]
[Pages 45662-45663]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-11291]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifiers: CMS-10526]
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (PRA), federal agencies are required to publish notice in
the Federal Register concerning each proposed collection of
information, including each proposed extension or reinstatement of an
existing collection of information, and to allow a second opportunity
for public comment on the notice. Interested persons are invited to
send comments regarding the burden estimate or any other aspect of this
collection of information, including the necessity and utility of the
proposed information collection for the proper performance of the
agency's functions, the accuracy of the estimated burden, ways to
enhance the quality, utility, and clarity of the information to be
collected, and the use of automated collection techniques or other
forms of information technology to minimize the information collection
burden.
DATES: Comments on the collection(s) of information must be received by
the OMB desk officer by June 24, 2024.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, please access
the CMS PRA website by copying and pasting the following web address
into your web browser: https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.
FOR FURTHER INFORMATION CONTACT: William Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. The term ``collection of
information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and
includes agency requests or requirements that members of the public
submit reports, keep records, or provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires
federal agencies to publish a 30-day notice in the Federal Register
concerning each proposed collection of information, including each
proposed extension or reinstatement of an existing collection of
information, before submitting the collection to OMB for approval. To
comply with this requirement, CMS is publishing this notice that
summarizes the following proposed collection(s) of information for
public comment:
1. Type of Information Collection Request: Extension without change
of a currently approved collection; Title of Information Collection:
Cost-Sharing Reduction Reconciliation Use: Under established Department
of Health and Human Services (HHS) regulations, although cost-sharing
reduction (CSR) payments are not being advanced to qualified health
plan (QHP) issuers at the present time, issuers are still permitted to
submit data that compares the CSR-eligible enrollment for each issuer
with their actual CSRs provided
[[Page 45663]]
by the issuer for covered services for each eligible enrollee in a
benefit year. HHS will compare this CSR-eligible enrollment with the
actual CSRs provided by the issuers that participate in the optional
data submission window to verify the issuer's reporting of CSRs
provided. This revised collection does not add any data elements and
continues to make summary plan level reporting optional.
Based upon CMS' experience in the CSR data collection and
evaluation process, CMS is not making any substantive changes to this
information collection. Form Number: CMS-10526 (OMB Control Number:
0938-1266); Frequency: Annually; Affected Public: Private Sector,
Business or other for-profit and not-for-profit institutions; Number of
Respondents: 150; Number of Responses: 150 Total Annual Hours: 2,363.
(For policy questions regarding this collection, contact Deborah Noymer
at 301-448-3755.)
William N. Parham, III,
Director, Division of Information Collections and Regulatory Impacts,
Office of Strategic Operations and Regulatory Affairs.
[FR Doc. 2024-11291 Filed 5-22-24; 8:45 am]
BILLING CODE 4120-01-P